Epithelial-to-mesenchymal transition is not a major modulating factor in the cytotoxic response to natural products in cancer cell lines
buir.contributor.author | Küçükkaraduman, Barş | |
buir.contributor.author | Çiçek, Ekin Gökçe | |
buir.contributor.author | Akbar, Muhammad Waqas | |
buir.contributor.orcid | Küçükkaraduman, Barş|0000-0002-5475-281X | |
buir.contributor.orcid | Akbar, Muhammad Waqas|0000-0003-4458-2236 | |
dc.citation.epage | 15 | en_US |
dc.citation.issueNumber | 19 | en_US |
dc.citation.spage | 1 | en_US |
dc.citation.volumeNumber | 26 | en_US |
dc.contributor.author | Küçükkaraduman, Barş | |
dc.contributor.author | Çiçek, Ekin Gökçe | |
dc.contributor.author | Akbar, Muhammad Waqas | |
dc.contributor.author | Demirkol Canlı, Seçil | |
dc.contributor.author | Vural, Burçak | |
dc.contributor.author | Gure, Ali Osmay | |
dc.date.accessioned | 2022-02-18T11:54:50Z | |
dc.date.available | 2022-02-18T11:54:50Z | |
dc.date.issued | 2021-09-27 | |
dc.department | Department of Molecular Biology and Genetics | en_US |
dc.description.abstract | Numerous natural products exhibit antiproliferative activity against cancer cells by modulating various biological pathways. In this study, we investigated the potential use of eight natural compounds (apigenin, curcumin, epigallocatechin gallate, fisetin, forskolin, procyanidin B2, resveratrol, urolithin A) and two repurposed agents (fulvestrant and metformin) as chemotherapy enhancers and mesenchymal-to-epithelial (MET) inducers of cancer cells. Screening of these compounds in various colon, breast, and pancreatic cancer cell lines revealed anti-cancer activity for all compounds, with curcumin being the most effective among these in all cell lines. Although some of the natural products were able to induce MET in some cancer cell lines, the MET induction was not related to increased synergy with either 5-FU, irinotecan, gemcitabine, or gefitinib. When synergy was observed, for example with curcumin and irinotecan, this was unrelated to MET induction, as assessed by changes in E-cadherin and vimentin expression. Our results show that MET induction is compound and cell line specific, and that MET is not necessarily related to enhanced chemosensitivity. | en_US |
dc.description.provenance | Submitted by Türkan Cesur (cturkan@bilkent.edu.tr) on 2022-02-18T11:54:50Z No. of bitstreams: 1 Epithelial-to-Mesenchymal_Transition_Is_Not_a_Major_Modulating_Factor_in_the_Cytotoxic_Response_to_Natural_Products_in_Cancer_Cell_Lines.pdf: 3250371 bytes, checksum: c46cab30f8410d9ffc6d3e63a8d163c3 (MD5) | en |
dc.description.provenance | Made available in DSpace on 2022-02-18T11:54:50Z (GMT). No. of bitstreams: 1 Epithelial-to-Mesenchymal_Transition_Is_Not_a_Major_Modulating_Factor_in_the_Cytotoxic_Response_to_Natural_Products_in_Cancer_Cell_Lines.pdf: 3250371 bytes, checksum: c46cab30f8410d9ffc6d3e63a8d163c3 (MD5) Previous issue date: 2021-09-27 | en |
dc.identifier.doi | 10.3390/molecules26195858 | en_US |
dc.identifier.eissn | 1420-3049 | |
dc.identifier.uri | http://hdl.handle.net/11693/77513 | |
dc.language.iso | English | en_US |
dc.publisher | MDPI AG | en_US |
dc.relation.isversionof | https://doi.org/10.3390/molecules26195858 | en_US |
dc.source.title | Molecules | en_US |
dc.subject | Natural products | en_US |
dc.subject | Cancer | en_US |
dc.subject | Chemotherapy resistance | en_US |
dc.subject | Epithelial-to-mesenchymal transition | en_US |
dc.subject | Mesenchymal-to-epithelial transition | en_US |
dc.title | Epithelial-to-mesenchymal transition is not a major modulating factor in the cytotoxic response to natural products in cancer cell lines | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Epithelial-to-Mesenchymal_Transition_Is_Not_a_Major_Modulating_Factor_in_the_Cytotoxic_Response_to_Natural_Products_in_Cancer_Cell_Lines.pdf
- Size:
- 3.1 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.69 KB
- Format:
- Item-specific license agreed upon to submission
- Description: